IDSAVerified account

@IDSAInfo

News & information from the Infectious Diseases Society of America, a community of 12,000+ physicians, scientists & public health experts who specialize in ID.

Arlington, VA
idsociety.org
Joined September 2009
2,074 Photos and videos Photos and videos

Tweets

You blocked @IDSAInfo

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @IDSAInfo

  1. 4 hours ago

    Dial Hewlett, MD, FIDSA warns about the shortcomings of COVID-19 testing, explaining that while someone may test negative, they might develop symptoms the next day & expose others to infection—a risk of the “test-out” situation. More on COVID-19 testing:

    1 retweet 4 likes
    Undo
  2. 6 hours ago

    Molecular testing has the highest sensitivity for ruling out COVID but issues with access, turn-around time, and cost and supplies are making tests difficult to provide, says , MD. Our new media briefing shares the latest on COVID-19 testing:

    1 retweet 8 likes
    Undo
  3. 7 hours ago

    "I love the fact that we were working w/ people from diverse backgrounds…we identified common problems & learned alternative methods and strategies,” of . Apply to the IDSA Leadership Institute by Nov. 12:

    2 likes
    Undo
  4. Retweeted
    23 hours ago

    Time to submit session suggestions for IDWeek 2022! Let’s hear your great ideas!

    6 retweets 15 likes
    Undo
  5. Retweeted
    Oct 28

    Check out the page for the most up-to-date info

    2 retweets 5 likes
    Undo
  6. 21 hours ago

    COVID-19 vaccines don’t persist in the body, says @RMKGhandi. Rather, protein from the vaccine lasts for a short time and the immune system is built up. Learn more by watching our recent media briefing on COVID-19 therapies:

    4 retweets 6 likes
    Undo
  7. Oct 28

    Visit the redesigned Science Speaks blog! 🌐 IDSA’s & ’s global health blog has a new look & easier ways to view content by topic, disease & author. Check out a new post from Daniel Lucey, MD, FIDSA, who reviews data on the AY.4.2. delta subvariant:

    2 retweets 5 likes
    Undo
  8. Retweeted
    Oct 28

    To put this in some context, this recommendation was formulated after the results of the TOGETHER trial on fluvoxamine were available as a preprint. Hoping for results from other fluvoxamine studies ASAP. 1/

    Among ambulatory patients w/ COVID-19, IDSA guideline panel recommends only in the context of a clinical trial. New recommendations on the use of fluvoxamine in ambulatory patients is available in IDSA’s :
    1 reply 4 retweets 11 likes
    Show this thread
    Show this thread
    Undo
  9. Retweeted
    Oct 28

    As showed, older Americans are at higher risk for acquiring infection and disease. Alongside and , we analyzed how superbugs impact this same population. The cost of lives and dollars was high. How can we help address this?

    1 reply 5 retweets 3 likes
    Undo
  10. Oct 28

    Before vaccination, caused 135 million cases & >6 million deaths globally each yr. A new JID supplement article reviews measles vaccine development & feasibility of eliminating the disease for good:

    7 retweets 15 likes
    Undo
  11. Oct 28

    Among ambulatory patients w/ COVID-19, IDSA guideline panel recommends only in the context of a clinical trial. New recommendations on the use of fluvoxamine in ambulatory patients is available in IDSA’s :

    10 retweets 21 likes
    Undo
  12. Oct 27

    OFID’s 2nd October Case of the Month looks at a case of treatment-emergent resistance to bictegravir in a person recently diagnosed with HIV:

    3 retweets 7 likes
    Undo
  13. Retweeted
    Oct 27

    NEW STUDY! ✔️8 mths of waning ⬇️ protection of against all infections from 80% to 60.4% ✔️3rd dose (which ⬆️ neutralizing titers 25.9X relative to levels post 8 mths of waning) ⬆️ protection to 87.2%

    1 reply 9 retweets 14 likes
    Undo
  14. Oct 27

    “Treatments are a backup to vaccines,” says . “Our priority must be to vaccinate everyone who is eligible because that is the way we’re going to get out of this pandemic.” Watch our recent media briefing on COVID-19 therapies:

    5 retweets 19 likes
    Undo
  15. Oct 27

    “Pandemics are like serious fires. We have to prepare for them...so that when the fire does come, we have a plan in place for it,” says Dial Hewlett, MD, FIDSA. highlights yesterday’s media briefing () on COVID-19 testing:

    2 retweets 3 likes
    Undo
  16. Oct 27

    And take action by asking your Representative to cosponsor the BIO Preparedness Workforce Act.

    3 likes
    Show this thread
    Show this thread
    Undo
  17. Oct 27

    ICYMI, watch IDSA Treasurer testify on behalf of IDSA in support of the BIO Preparedness Workforce Act () at yesterday’s hearing:

    1 reply 4 likes
    Show this thread
    Show this thread
    Undo
  18. Oct 26

    The EUA mechanism should be standardized and the process should be explicit, transparent and timely, says Adarsh Bhimraj, MD, FIDSA (). Watch our new media briefing on COVID-19 therapies:

    2 retweets 3 likes
    Undo
  19. Retweeted
    Oct 26

    BREAKING NEWS! Committee votes in favor (17-0, 1 abstain) of EUA of - for 5-11 yr olds The will meet Nov. 2 & 3, & will vote on whether to recommend the vaccine for this age group

    29 retweets 55 likes
    Undo
  20. Oct 26

    Visit CID’s curated content collections for October, on COVID transmission, HIV/AIDS and vector-borne diseases:

    5 likes
    Undo

@IDSAInfo hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·